We performed a retrospective cohort study of 1, 238 primary NSCLC patients who had EGFR gene testing in Affiliated Hospital of Qingdao University from January 1, 2015 to December 31, 2016 and identified 603 patients with single mutation and 59 patients with double mutation. Here, EGFR is linked to non-small cell lung carcinoma.